newdrugapprovals.org
Polymorph case study……….Duvelisib
Duvelisib Infinity and AbbVie partner to develop and commercialise duvelisib for cancer INK 1197; IPI 145; 8-Chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-1(2H)-isoquinolinone 1(2H)-I…